SUMMARY Plasma calcium and phosphate concentrations and alkaline phosphatase activities were examined retrospectively in 50 patients with histologically proven osteomalacia and 50 age-and sexmatched control subjects with normal bone histology. An abnormal plasma alkaline phosphatase activity was more useful than an abnormal plasma calcium or phosphate concentration in distinguishing between normal and osteomalacic subjects, producing a false-negative rate of 140% and a falsepositive rate of 8 %. False-negative and false-positive rates of 10 % and 8 % respectively were obtained when the presence of an abnormality in any one of the three biochemical measurements was used as a predictor of histological osteomalacia. When discriminant analysis was applied to plasma calcium, phosphate and alkaline phosphatase together a false-negative rate of 12 %/ and a false-positive rate of 0 % was obtained.
Sixty-two patients in whom a diagnosis of osteomalacia was suspected were investigated prospectively, using both single biochemical abnormalities and the classification functions derived from the discriminant analysis of all three biochemical measurements to predict the presence or absence of histological osteomalacia. Plasma alkaline phosphatase activity gave false-negative and falsepositive rates of 10% and 32% respectively but was a more reliable predictor of abnormal bone histology than were plasma calcium or plasma phosphate concentrations or the presence of an abnormality in any one of the three measurements. Discriminant analysis using plasma calcium, phosphate and alkaline phosphatase together produced a false-negative rate of 160% and a falsepositive rate of 10 %.
We conclude that plasma alkaline phosphatase activity is the best single routine biochemical screening test for osteomalacia, although a high false-positive rate may occur. Direct discriminant analysis of plasma calcium, phosphate and alkaline phosphatase together provides a more sensitive method of detecting histological osteomalacia which should be useful in determining the prevalence of osteomalacia within high-risk populations.
Osteomalacia is characterised histologically by defective bone mineralisation producing an increase in osteoid volume and seam thickness with decreased calcification fronts and a reduced mineralisation rate.
The most common clinical manifestations are bone pain and proximal muscle weakness. Biochemically, hypocalcaemia, hypophosphataemia and a raised plasma alkaline phosphatase activity may occur. However, the clinical symptoms and signs are *Present address: Department of Pathology, Royal Berk- shire Hospital, Reading. Accepted for publication 30 September 1981 frequently non-specific and it is usually difficult or impossible to make a definite diagnosis on the basis of the clinical features until late in the course of the disease. Similarly, the biochemical changes are variable; histological osteomalacia may be seen in patients with normal plasma calcium, phosphate and alkaline phosphatasel 2 whilst hypocalcaemia, hypophosphataemia or a raised plasma alkaline phosphatase activity may be due to causes other than osteomalacia. The radiological changes of osteomalacia, namely pseudofractures and unhealing pathological fractures, are usually seen only in the advanced stages of the disease. 625 Because of the unreliability of clinical, biochemical and radiological changes in osteomalacia, examination of bone histology is at present the only accurate method for its diagnosis. Since osteomalacia is generalised in its distribution throughout the skeleton, biopsy from a single site is representative; in practice the iliac crest is the site most commonly used. However, bone biopsy, although safe is an invasive procedure and the processing and quantification of bone histological sections are time-consuming and require facilities that are not widely available. In addition, bone biopsy is obviously an unsuitable method of screening populations for osteomalacia.
In this study we have compared plasma calcium, phosphate and alkaline phosphatase measurements in 50 patients with osteomalacia and 50 age-and sex-matched healthy control subjects with normal bone histology and have applied discriminant analysis to these three biochemical values. Sixty-two patients with suspected osteomalacia were then studied prospectively, using both single biochemical abnormalities and the classification functions derived from the discriminant analysis to predict the presence or absence of histological osteomalacia. calcium concentration and a raised plasma alkaline phosphatase activity, two had only a raised plasma alkaline phosphatase and three had only a raised corrected plasma calcium concentration. The cause of these biochemical abnormalities was not established.
The false-negative and false-positive rates produced by predicting histological osteomalacia from the plasma calcium, phosphate or alkaline phosphatase measurements individually are shown in Table 3 . When discriminant analysis was applied to the biochemical data, the lowest false-negative tate (12%) was produced by entering calcium, phosphate and alkaline phosphatase into the analysis together and taking the discriminant score which gave zero false-positives as -0-4 (Fig 4) . The formula for calculation of the discriminant score is: 8-51 + (0-4 x alkaline phosphatase)-(3-42 x corrected calcium)-(1-46 x phosphate). The five falsenegative results included two of the five patients with normal plasma biochemistry; the remaining three patients had a normal plasma calcium and phosphate concentration and a raised plasma alkaline phosphatase activity (15, 16 and 17 King Armstrong Units/dl; normal range 2-11 KAU/dl). The osteoid volume in these patients ranged from 12-1-28-4% (mean 18-1 %).
PROSPECTIVE STUDY (FIGS 1-4, TABLE 4)
Of the 62 patients studied prospectively 31 had histological evidence of osteomalacia, bone histology being normal in the remainder. Three of the patients with osteomalacia had normal plasma biochemistry. Of the 31 patients with normal bone histology, plasma group.bmj.com on June 20, 2017 -Published by http://jcp.bmj.com/ Downloaded from biochemistry was abnormal in 13; two patients had hypocalcaemia alone, two had hypophosphataemia alone and nine had a raised plasma alkaline phosphatase activity. The use of an abnormal plasma calcium or phosphate concentration again produced high false-negative rates when used to predict histological osteomalacia and, as in the retrospective study, the plasma alkaline phosphatase activity was the most sensitive individual predictor of bone histology. However, the false-positive rate of 32 % which followed from plasma alkaline phosphatase measurements was considerably higher than that obtained in the retrospective sample. Similarly, when the presence of an abnormality in any of the three biochemical measurements was used the false-positive rate (42%) was much higher than that found in the retrospective study.
The classification functions derived from the discriminant analysis into which calcium, phosphate and alkaline phosphatase had been entered were used to assign the prospective cases to normal and abnormal bone histology groups. Five cases were incorrectly assigned to the normal group and three were incorrectly assigned to the abnormal group giving a false-negative and false-positive rate of 16 % and 9 7 % respectively. None of the nine Asians with normal bone histology produced a false-positive result. The three false-positive results comprised two patients with a raised plasma alkaline phosphatase activity (17 KAU/dl in both cases) and one with a low corrected plasma calcium concentration (2-13 mmol/l) and a raised plasma alkaline phosphatase activity (12 KAU/dl). The five false-negative results were obtained in the three patients with osteomalacia who had normal plasma biochemistry and in two patients with a normal plasma calcium and phosphate concentration but a raised plasma alkaline phosphatase activity (15 and 18 KAU/dl). The osteoid volume in these five patients ranged from 10-2-19-0% (mean 13A4).
Discussion
Measurement of plasma calcium, phosphate and alkaline phosphatase is commonly carried out as a diagnostic test for osteomalacia. Our results demonstrate that when an abnormal plasma calcium or phosphate concentration is used to predict histological osteomalacia a high false-negative rate is obtained, although the false-positive rate is low. Plasma alkaline phosphatase activity appears to be the most sensitive single test with which to detect osteomalacia but the low false-positive rate which was found in the case-control study using either an abnormal plasma alkaline phosphatase or any biochemical abnormality could not be replicated in the prospective sample which included patients suspected of having osteomalacia. In contrast, when direct discriminant analysis was applied to the plasma calcium, phosphate and alkaline phosphatase values together the high true positive rate of the retrospective study was replicated in the prospective sample and a false-negative rate of only 16 % was obtained. Moreover, the patients in whom falsenegative results were obtained had only mild osteomalacia, the mean osteoid volume in these cases being 134%.
Since the retrospective study included only nonAsian caucasian controls the inclusion of Asians in this group might have lowered the cut-off point of the discriminant functions, thus increasing the number of false-negatives. However, although biochemical abnormalities suggestive of osteomalacia are relatively common in Asian immigrants, there is no evidence that Asians with normal bone histology differ biochemically from non-Asian caucasians. Moreover, the use of the classification functions based on the retrospective study was validated by the prospective series in which nine Asian patients with normal bone histology were included; of these, none produced a false-positive result.
In this study the discriminant function was based upon biochemical measurements in subjects with normal renal and hepatic function. It is unlikely to be applicable to patients with severe renal dysfunction because of phosphate retention and its secondary effects on the plasma calcium concentration. Similarly, in patients with cholestatic liver disease the increase in the liver isoenzyme of alkaline phosphatase is likely to produce misleading results. In patients without severe renal or hepatic dysfunction however, direct discriminant analysis of the corrected plasma calcium, plasma phosphate and plasma alkaline phosphatase provides a formula which satisfactorily predicts the presence or absence of histological osteomalacia.
Although the use of an abnormal calcium or phosphate concentration on their own both produced high false-negative rates the false-positive rates were low. Calcium would probably have produced a higher false-positive rate if the uncorrected plasma calcium concentration had been used because of the low plasma albumin concentration often associated with malabsorption. The relatively low discriminatory power of alkaline phosphatase is probably due to two factors. First, total plasma alkaline phosphatase is a measure of five different isoenzymes, only one of which originates from bone; raised activities in other isoenzymes, particularly those arising in liver, will cause an increase in the total plasma alkaline phosphatase activity. Separation of the isoenzymes would probably improve 
